Pertuzumab and T-DM1: New perspectives in the treatment of HER2-positive breast cancer
Crossref DOI link: https://doi.org/10.1007/s10269-015-2484-5
Published Online: 2015-02-06
Published Print: 2015-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Guiu, S.
Fumoleau, P.
Text and Data Mining valid from 2015-02-06